Xiaoyue Wang
Ph.D., Executive MBA
Heidelberg
Summary
Agile Mindset, Passion for Business Opportunities, and Business Development to transform biotechnology to save the patient life, excited by Innovation. Strong business acumen with scientific knowledge in healthcare and am looking for new challenges.
Overview
10
10
years of professional experience
13
13
years of post-secondary education
4
4
Languages
Work History
Director of Business Development Oncology
Vela Diagnostics Germany GmbH
Heidelberg
09.2021 - Current
- Developed and implemented a Market Entry Strategy for Oncology Diagnostics products in the EMEA market.
- Developed IVDR registration strategy.
- Engaged with KOLs of Oncologists and Pathologists and set up clinical studies across different countries in EMEA, e.g., Germany, France, Italy, Portugal, and Turkey.
- Actively listened to customers, handled concerns quickly, and escalated major issues to R&D to improve the products.
- Managed cross-country sales teams and collaborated with the support team.
- Responsible for the P&L for the Oncology product line across the EMEA market.
- Successfully installed the first reference customer in EMEA.
Vice President of Business Development and Sales
Molecular Health
Heidelberg
01.2019 - 08.2021
- International business development activities related to biotech companies, investors, clinical diagnostic labs, distributors, and pharmaceutical companies.
- Developed country-specific CDx or IVD strategies for market entries of CE-IVD products.
- Successfully developed go-to-market strategy and implementation for CE-IVD and AI-driven digital products.
- Successful market expansion drove strategic alliance partnership growth more than twice yearly.
- Achieved end-to-end B2B, B2C Business Development strategic alliances deal with more than two times yearly growth.
- Team management responsibilities, cross-continental cross-culture local representatives.
Business Development & Sales Manager
Molecular Health
Heidelberg
03.2017 - 12.2018
- Identified KOL physicians, e.g., oncologists/human geneticists in leading clinics and clinical diagnostic labs, and arranged face-to-face meetings/seminars
- Identified partners for creating joint ventures, collaborations, and local distributions, followed by LOI and cooperation agreement contract negotiations.
- Cross-function communication with legal counsel and national authorities, e.g., PMDA, CFDA.
- Developed comprehensive, cross-cultural market entry/sales business strategies for new international markets.
- Successfully entered multiple markets in APAC and increased sales by 25%, e.g., Japan, Hong Kong, and South Korea.
- Identified customer needs and coordinated innovative strategies to create a new BRCA testing product with the product development team.
- Created reports and presentations are detailing business development activities.
NGS Platform Leader
Perkin Elmer
Suzhou
01.2016 - 01.2017
- Owned and managed about 600,000 € budget, installed all equipment, and hired team members.
- Built NGS technology platform, designed gene panels for diagnostic applications in inherited diseases, and led team to set up data analysis server and establish clinical data analysis pipeline.
- Hired and managed an NGS team consisting of 12 staff, including technicians, bioinformaticians, and genetic counselors.
- Conducted clinical test validation and generated validation reports for clinical tests with the team.
Senior Scientist
German Cancer Research Center (DKFZ)
Heidelberg
10.2011 - 06.2015
- Managed technicians and coached Master Students to conduct experiments in a laboratory environment for metabolism cancer research purposes.
- Simultaneously managed several complex projects, meeting all pertinent milestones.
- Drove ongoing advances in cancer & metabolic type II diabetes, NGS, and data analysis, planning and managing projects, with results presented at numerous seminars and scientific meetings.
R&D Scientist - Internship
PROCTER & GAMBLE (P&G)
Brussels
08.2011 - 10.2011
- Developed innovative testing methods to improve product market research strategies. Initiated and organized several company meetings with colleagues from both product design and market research departments.
- Commended by managers for outstanding work and contributions to the department.
Education
ESSEC & MANNHEIM Executive MBA - Business Administration And Management
Mannheim Business School
Mannheim 10.2020 - 06.2022
ESSEC & MANNHEIM Executive MBA - Business Administration And Management
ESSEC Business School
Paris, France 10.2020 - 06.2022
Ph.D. - Genetics And Developmental Biology
Max-Planck Instittue For Developmental Biology
Tübingen 04.2007 - 03.2011
Master of Science - Graduate School of Medicine
Kyoto University
Kyoto, Japan 04.2005 - 03.2007
Bachelor of Science - Applied Life Science
Kyoto University
Kyoto, Japan 04.2001 - 03.2005
Skills
Business development and planning
Masters of Business Administration (MBA)
Corporate finance and Project Finance
Cross-organizational/cross-functional project management project management
Trained in cross-cultural communication
Deep knowledge of Healthcare landscape
Due diligent evaluation process
Multilingual skills
Timeline
Director of Business Development Oncology
Vela Diagnostics Germany GmbH
09.2021 - Current
ESSEC & MANNHEIM Executive MBA - Business Administration And Management
Mannheim Business School
10.2020 - 06.2022
ESSEC & MANNHEIM Executive MBA - Business Administration And Management
ESSEC Business School
10.2020 - 06.2022
Vice President of Business Development and Sales
Molecular Health
01.2019 - 08.2021
Business Development & Sales Manager
Molecular Health
03.2017 - 12.2018
NGS Platform Leader
Perkin Elmer
01.2016 - 01.2017
Senior Scientist
German Cancer Research Center (DKFZ)
10.2011 - 06.2015
R&D Scientist - Internship
PROCTER & GAMBLE (P&G)
08.2011 - 10.2011
Ph.D. - Genetics And Developmental Biology
Max-Planck Instittue For Developmental Biology
04.2007 - 03.2011
Master of Science - Graduate School of Medicine
Kyoto University
04.2005 - 03.2007
Bachelor of Science - Applied Life Science
Kyoto University
04.2001 - 03.2005